IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 50 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $26,000 | -96.8% | 46,347 | -94.2% | 0.00% | -100.0% |
| Q3 2021 | $820,000 | +14.0% | 795,871 | +32.8% | 0.00% | 0.0% |
| Q2 2021 | $719,000 | +247.3% | 599,471 | +277.1% | 0.00% | +100.0% |
| Q1 2021 | $207,000 | -11.9% | 158,971 | +148.4% | 0.00% | 0.0% |
| Q4 2020 | $235,000 | +108.0% | 63,996 | +20.8% | 0.00% | – |
| Q3 2020 | $113,000 | +16.5% | 52,971 | -1.8% | 0.00% | – |
| Q2 2020 | $97,000 | +34.7% | 53,920 | -0.8% | 0.00% | – |
| Q1 2020 | $72,000 | -47.1% | 54,382 | -27.5% | 0.00% | – |
| Q4 2019 | $136,000 | -47.9% | 74,982 | -16.9% | 0.00% | -100.0% |
| Q3 2019 | $261,000 | +4.0% | 90,282 | -3.9% | 0.00% | 0.0% |
| Q2 2019 | $251,000 | +3.3% | 93,982 | -1.6% | 0.00% | 0.0% |
| Q1 2019 | $243,000 | +196.3% | 95,482 | +222.5% | 0.00% | – |
| Q4 2018 | $82,000 | -61.9% | 29,607 | +22.7% | 0.00% | -100.0% |
| Q3 2018 | $215,000 | – | 24,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 4,839,895 | $12,342,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 65,448 | $167,000 | 0.02% |
| MYCIO WEALTH PARTNERS, LLC | 55,815 | $142,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 187,445 | $478,000 | 0.01% |
| ZACKS INVESTMENT MANAGEMENT | 168,781 | $430,000 | 0.01% |
| Candriam S.C.A. | 290,000 | $740,000 | 0.01% |
| Assenagon Asset Management S.A. | 355,728 | $907,000 | 0.01% |
| Palo Alto Investors LP | 77,044 | $196,000 | 0.01% |
| HOLLENCREST CAPITAL MANAGEMENT | 21,571 | $55,000 | 0.01% |
| Walleye Capital LLC | 16,022 | $41,000 | 0.01% |